UCSF
San Francisco, California, United States
Ajai Chari, M.D. is the Director of the Multiple Myeloma Program and a Professor of Clinical Medicine at the University of California, San Francisco.
Dr. Chari’s research interests include the development of novel chemotherapy regimens, including Phase 1 and 2 studies. He has served as the principal investigator (PI) of several investigator-initiated trials as well as the national and international PI of several industry-sponsored studies. With a long standing dedication to research, Dr Chari has been involved in each of the therapies approved in multiple myeloma over the last two decades. He has published numerous articles in the field and is a frequently invited speaker at national and international meetings.
Dr. Chari received undergraduate degree from Stanford University and his medical degree from the David Geffen School of Medicine at University of California – Los Angeles. He completed his residency in internal medicine at Columbia University Medical Center and a fellowship in hematology and oncology at the University of California – San Francisco.
Session X: Upfront Treatment of Myeloma
Friday, October 20, 2023
10:00 AM – 11:55 AM ET
Friday, October 20, 2023
10:45 AM – 11:05 AM ET
Panel Discussion and Post-Session Audience Survey
Friday, October 20, 2023
11:35 AM – 11:55 AM ET